世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033802

感染症診断市場レポート 2022-2032

Visiongain

Infectious Disease Diagnostics Market Report 2022-2032

発刊日 2022/12/16

言語英語

体裁PDF/325ページ

ライセンス/価格325ページ

0000033802

Single - 1 Year License
(Team License - Up to 6 Users) - 1 Year License
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数6人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

製品別予測 (機器、試薬、キット、消耗品、ソフトウェア & サービス)、試験の種類別 (臨床検査および POC 検査)、技術別 (免疫診断、ポリメラーゼ連鎖反応 (PCR)、DNA シーケンシング&次世代シーケンシング (NGS)、臨床微生物学、その他)、用途別 (COVID-19、ヒト免疫不全ウイルス (HIV)、院内感染 (HAI)、肝炎、ヒトパピローマウイルス (HPV)、結核 (TB)、インフルエンザ、その他)、エンドユーザー別 (診断研究所、病院および診療所、研究機関、在宅医療、その他) 、 地域&主要国市場分析、プラス主要企業の分析 およびCOVID-19 の影響と回復パターン分析

世界の感染症診断市場は2021年に282億7,220万ドルと評価され、2022年から 2032年までの予測期間中6.61%のCAGRで成長すると予想されます。

レポート詳細

目次

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Infectious Disease Diagnostics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Prevalence of Infectious Diseases
3.2.1.2 Shift in Focus from Centralized Laboratories to Decentralized POC Testing
3.2.1.3 Increase in Funding from Private & Government Organizations for Diagnostic Service Center
3.2.2 Market Restraining Factors
3.2.2.1 Unfavourable Reimbursement Scenario
3.2.2.2 Shortage of Skilled Professionals
3.2.3 Market Opportunities
3.2.3.1 Growing opportunities in growing economies
3.2.3.2 Introduction of cost-effective and reliable test kits
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Infectious Disease Diagnostics Market Analysis by Product
4.1 Key Findings
4.2 Product Segment Growth Prospects
4.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
4.4 Instrument
4.4.1 Market Size by Region, 2022-2032 (US$ Million)
4.4.2 Market Share by Region, 2022 & 2032 (%)
4.5 Reagents, Kits, and Consumables
4.5.1 Market Size by Region, 2022-2032 (US$ Million)
4.5.2 Market Share by Region, 2022 & 2032 (%)
4.6 Software & Services
4.6.1 Market Size by Region, 2022-2032 (US$ Million)
4.6.2 Market Share by Region, 2022 & 2032 (%)

5 Infectious Disease Diagnostics Market Analysis by Type of Testing
5.1 Key Findings
5.2 Type of Testing Segment Growth Prospects
5.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
5.4 Laboratory Testing
5.4.1 Market Size by Region, 2022-2032 (US$ Million)
5.4.2 Market Share by Region, 2022 & 2032 (%)
5.5 POC Testing
5.5.1 Market Size by Region, 2022-2032 (US$ Million)
5.5.2 Market Share by Region, 2022 & 2032 (%)

6 Infectious Disease Diagnostics Market Analysis by Technology
6.1 Key Findings
6.2 Technology Segment Growth Prospects
6.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
6.4 Immunodiagnostics
6.4.1 Market Size by Region, 2022-2032 (US$ Million)
6.4.2 Market Share by Region, 2022 & 2032 (%)
6.6 Polymerase Chain Reaction (PCR)
6.6.1 Market Size by Region, 2022-2032 (US$ Million)
6.6.2 Market Share by Region, 2022 & 2032 (%)
6.7 DNA Sequencing and Next-Generation Sequencing (NGS)
6.7.1 Market Size by Region, 2022-2032 (US$ Million)
6.7.2 Market Share by Region, 2022 & 2032 (%)
6.8 Clinical Microbiology
6.8.1 Market Size by Region, 2022-2032 (US$ Million)
6.8.2 Market Share by Region, 2022 & 2032 (%)
6.9 Other technologies
6.9.1 Market Size by Region, 2022-2032 (US$ Million)
6.9.2 Market Share by Region, 2022 & 2032 (%)

7 Infectious Disease Diagnostics Market Analysis by Application
7.1 Key Findings
7.2 Application Segment Growth Prospects
7.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
7.4 COVID-19
7.4.1 Market Size by Region, 2022-2032 (US$ Million)
7.4.2 Market Share by Region, 2022 & 2032 (%)
7.5 Human Immunodeficiency Virus (HIV)
7.5.1 Market Size by Region, 2022-2032 (US$ Million)
7.5.2 Market Share by Region, 2022 & 2032 (%)
7.6 Healthcare-Associated Infections (HAIs)
7.6.2 Market Share by Region, 2022 & 2032 (%)
7.7 Hepatitis
7.7.1 Market Size by Region, 2022-2032 (US$ Million)
7.7.2 Market Share by Region, 2022 & 2032 (%)
7.8 Human Papillomavirus (HPV)
7.8.2 Market Share by Region, 2022 & 2032 (%)
7.9 Tuberculosis (TB)
7.9.1 Market Size by Region, 2022-2032 (US$ Million)
7.9.2 Market Share by Region, 2022 & 2032 (%)
7.10 Influenza
7.10.1 Market Size by Region, 2022-2032 (US$ Million)
7.10.2 Market Share by Region, 2022 & 2032 (%)
7.11 Other Infectious Diseases
7.11.1 Market Size by Region, 2022-2032 (US$ Million)
7.11.2 Market Share by Region, 2022 & 2032 (%)

8 Infectious Disease Diagnostics Market Analysis by End User
8.1 Key Findings
8.2 End User Segment Growth Prospects
8.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by End User
8.4 Diagnostic Laboratories
8.4.2 Market Share by Region, 2022 & 2032 (%)
8.5 Hospitals & Clinics
8.5.1 Market Size by Region, 2022-2032 (US$ Million)
8.5.2 Market Share by Region, 2022 & 2032 (%)
8.6 Research Institutes
8.6.1 Market Size by Region, 2022-2032 (US$ Million)
8.6.2 Market Share by Region, 2022 & 2032 (%)
8.7 Home Care Settings
8.7.1 Market Size by Region, 2022-2032 (US$ Million)
8.7.2 Market Share by Region, 2022 & 2032 (%)
8.8 Other End Users
8.8.1 Market Size by Region, 2022-2032 (US$ Million)
8.8.2 Market Share by Region, 2022 & 2032 (%)

9 Infectious Disease Diagnostics Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast
9.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

10 North America Infectious Disease Diagnostics Market Analysis
10.1 Key Findings
10.2 North America Infectious Disease Diagnostics Market Attractiveness Index
10.3 North America Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
10.4 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
10.5 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
10.6 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
10.7 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
10.8 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
10.9 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by End users
10.10 U.S. Infectious Disease Diagnostics Market Analysis
10.11 Canada Infectious Disease Diagnostics Market Analysis

11 Europe Infectious Disease Diagnostics Market Analysis
11.1 Key Findings
11.2 Europe Infectious Disease Diagnostics Market Attractiveness Index
11.3 Europe Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
11.4 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
11.5 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
11.6 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
11.7 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
11.8 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
11.9 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by End User
11.10 Germany Infectious Disease Diagnostics Market Analysis
11.11 UK Infectious Disease Diagnostics Market Analysis
11.12 France Infectious Disease Diagnostics Market Analysis
11.12 Italy Infectious Disease Diagnostics Market Analysis
11.13 Spain Infectious Disease Diagnostics Market Analysis
11.14 Russia Infectious Disease Diagnostics Market Analysis
11.15 Rest of Europe Infectious Disease Diagnostics Market Analysis

12 Asia Pacific Infectious Disease Diagnostics Market Analysis
12.1 Key Findings
12.2 Asia Pacific Infectious Disease Diagnostics Market Attractiveness Index
12.3 Asia Pacific Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
12.4 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
12.5 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
12.6 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
12.7 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
12.8 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
12.9 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users
12.10 Japan Infectious Disease Diagnostics Market Analysis
12.11 China Infectious Disease Diagnostics Market Analysis
12.12 India Infectious Disease Diagnostics Market Analysis
12.13 Australia Infectious Disease Diagnostics Market Analysis
12.14 South Korea Infectious Disease Diagnostics Market Analysis
12.15 Rest of Asia Pacific Infectious Disease Diagnostics Market Analysis

13 Latin America Infectious Disease Diagnostics Market Analysis
13.1 Key Findings
13.2 Latin America Infectious Disease Diagnostics Market Attractiveness Index
13.3 Latin America Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
13.4 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
13.5 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
13.6 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
13.7 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
13.8 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
13.9 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users
13.10 Brazil Infectious Disease Diagnostics Market Analysis
13.11 Mexico Infectious Disease Diagnostics Market Analysis
13.12 Rest of Latin America Infectious Disease Diagnostics Market Analysis

14 MEA Infectious Disease Diagnostics Market Analysis
14.1 Key Findings
14.2 MEA Infectious Disease Diagnostics Market Attractiveness Index
14.3 MEA Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million)
14.4 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Country
14.5 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Product
14.6 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing
14.7 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology
14.8 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Application
14.9 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users
14.10 GCC Infectious Disease Diagnostics Market Analysis
14.11 South Africa Infectious Disease Diagnostics Market Analysis
14.12 Rest of MEA Infectious Disease Diagnostics Market Analysis

15 Company Profiles
15.1 Competitive Landscape, 2021
15.2 Danaher Corporation
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue, 2017-2021
15.2.3.2 R&D, 2017-2021
15.2.3.3 Regional Market Shares, 2021
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 PerkinElmer Inc.
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2017-2021
15.3.3.2 R&D, 2017-2021
15.3.3.3 Regional Market Shares, 2021
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Abbott
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2017-2021
15.4.3.2 R&D, 2017-2021
15.4.3.3 Regional Market Shares, 2021
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 BioMérieux SA
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2017-2021
15.5.3.2 R&D, 2017-2021
15.5.3.3 Regional Market Shares, 2021
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 F. Hoffmann-La Roche Ltd
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2017-2021
15.6.3.2 R&D, 2017-2021
15.6.3.3 Regional Market Shares, 2021
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Becton, Dickinson and Company
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2017-2021
15.7.3.2 R&D, 2017-2021
15.7.3.3 Regional Market Shares, 2021
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Bio-Rad Laboratories
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2017-2021
15.8.3.2 R&D, 2017-2021
15.8.3.3 Regional Market Shares, 2021
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Siemens Healthineers
15.9.1 Company Snapshot
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2017-2021
15.9.3.2 R&D, 2017-2021
15.9.3.3 Regional Market Shares, 2021
15.9.4 Product Benchmarking
15.9.4 Strategic Outlook
15.10 Thermo Fisher Scientific
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2017-2021
15.10.3.2 R&D, 2017-2021
15.10.3.3 Regional Market Shares, 2021
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Quidel Corporation
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2017-2021
15.11.3.2 R&D, 2017-2021
15.11.3.3 Regional Market Shares, 2021
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

List of Tables
Table 1 Infectious Disease Diagnostics Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 3 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 4 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 5 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 6 Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 7 Instrument Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 8 Reagents, Kits, and Consumables Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 9 Software & Services Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR %)
Table 10 Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 11 Laboratory Testing Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 12 POC Testing Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 13 Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 14 Immunodiagnostics Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 15 Polymerase Chain Reaction (PCR) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 16 DNA Sequencing and Next-Generation Sequencing (NGS) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 17 Clinical Microbiology Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 18 Immunodiagnostics market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 19 Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 20 COVID-19 Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 21 Human Immunodeficiency Virus (HIV) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 23 Healthcare-Associated Infections (HAIs) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 24 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 25 Human Papillomavirus (HPV) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 26 Tuberculosis (TB) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 27 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 28 Other Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 29 Global Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 30 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 31 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 32 Research Institutes Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 33 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 34 Other End Users Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 35 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%))
Table 36 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario
Table 37 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario
Table 38 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario
Table 39 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario
Table 40 North America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 41 North America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 42 North America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 43 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR %)
Table 44 North America Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 45 North America Infectious Disease Diagnostics Market Forecast by End User, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 46 U.S. Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 47 Canada Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 48 Europe Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 49 Europe Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 50 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 51 Europe Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 52 Europe Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 53 Europe Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 54 Germany Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 55 UK Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 56 France Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 57 Italy Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 58 Spain Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 59 Russia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 60 Rest of Europe Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 61 Asia Pacific Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 62 Asia Pacific Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 63 Asia Pacific Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 64 Asia Pacific Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 65 Asia Pacific Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 66 Asia Pacific Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 67 Japan Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 68 China Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 69 India Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 70 Australia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 71 South Korea Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 72 Rest of Asia Pacific Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 73 Latin America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 74 Latin America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 75 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 76 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 77 Latin America Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 78 Latin America Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 79 Brazil Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 80 Mexico Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 81 Rest of Latin America Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 82 MEA Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 83 MEA Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 84 MEA Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 85 MEA Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 86 MEA Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%)
Table 87 MEA Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%)
Table 88 GCC Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 89 South Africa Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 90 Rest of MEA Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%)
Table 91 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Danaher Corporation: Product Benchmarking
Table 93 Danaher Corporation: Strategic Outlook
Table 94 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 PerkinElmer Inc.: Product Benchmarking
Table 96 PerkinElmer Inc.: Strategic Outlook
Table 97 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Abbott: Product Benchmarking
Table 99 Abbott: Strategic Outlook
Table 100 BioMérieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 BioMérieux SA: Product Benchmarking
Table 102 BioMérieux SA: Strategic Outlook
Table 103 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 105 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 106 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Becton, Dickinson and Company: Product Benchmarking
Table 108 Becton, Dickinson and Company: Strategic Outlook
Table 109 Bio-Rad Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Bio-Rad Laboratories: Product Benchmarking
Table 111 Bio-Rad Laboratories: Strategic Outlook
Table 112 Siemens Healthineers: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Siemens Healthineers: Product Benchmarking
Table 114 Siemens Healthineers: Strategic Outlook
Table 115 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Thermo Fisher Scientific: Product Benchmarking
Table 117 Thermo Fisher Scientific: Strategic Outlook
Table 118 Quidel Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Quidel Corporation: Product Benchmarking
Table 120 Quidel Corporation: Strategic Outlook
?

List of Figures
Figure 1 Global Clinical Trials Supply and Logistics Market Segmentation
Figure 2 Infectious Disease Diagnostics Market by Product: Market Attractiveness Index
Figure 3 Infectious Disease Diagnostics Market Attractiveness Index by Region
Figure 4 Infectious Disease Diagnostics : Market Dynamics
Figure 5 Global COVID Impact Analysis: Infectious Disease Diagnostics Market Recovery Scenarios
Figure 6 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
2027
Figure 7 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 8 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 9 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 10 Infectious Disease Diagnostics Market: Porter’s Five Forces Analysis
Figure 11 Infectious Disease Diagnostics Market: PEST Analysis
Figure 12 Infectious Disease Diagnostics Market Forecast by Product 2022, 2027, 2032 (Revenue, CAGR %)
Figure 13 Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 14 Infectious Disease Diagnostics Market Share Forecast by Product, 2022, 2027, 2032 (%)
f research laboratories and increased funding from public and private organizations for the development of diagnostic instruments in the pharmaceutical and biotechnology industry, the instruments segment is anticipated to experience significant growth during the forecast period.
Figure 15 Instrument Market Forecast by Region, 2022-2032 (US$ million)
Figure 16 Instrument Market Share Forecast by Region, 2022 & 2032 (%)
Figure 17 Reagents, Kits, and Consumables Market Forecast by Region, 2022-2032 (US$ million)
Figure 18 Reagents, Kits, and Consumables Market Share Forecast by Region, 2022 & 2032 (%)
Figure 19 Software & Services Market Forecast by Region, 2022-2032 (US$ million)
Figure 20 Software & Services Market Share Forecast by Region, 2022 & 2032 (%)
Figure 21 Infectious Disease Diagnostics Market Forecast by Type of Testing 2022, 2027, 2032 (Revenue, CAGR %)
Figure 22 Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 23 Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022, 2027, 2032 (%)
Figure 24 Laboratory Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 25 Laboratory Testing Market Share Forecast by Region, 2022 & 2032 (%)
Figure 26 POC Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 27 POC Testing Market Share Forecast by Region, 2022 & 2032 (%)
Figure 28 Infectious Disease Diagnostics Market Forecast by Technology 2022, 2027, 2032 (Revenue, CAGR%)
Figure 29 Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 30 Infectious Disease Diagnostics Market Share Forecast by Technology, 2022, 2027, 2032 (%)
Figure 31 Immunodiagnostics Market Forecast by Region, 2022-2032 (US$ million)
Figure 32 Immunodiagnostics Market Share Forecast by Region, 2022 & 2032 (%)
Figure 33 Polymerase Chain Reaction (PCR) Market Forecast by Region, 2022-2032 (US$ million)
Figure 34 Polymerase Chain Reaction (PCR) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 35 DNA Sequencing and Next-Generation Sequencing (NGS) Market Forecast by Region, 2022-2032 (US$ million)
Figure 36 DNA Sequencing and Next-Generation Sequencing (NGS) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 37 Clinical Microbiology Market Forecast by Region, 2022-2032 (US$ million)
Figure 38 Clinical Microbiology Market Share Forecast by Region, 2022 & 2032 (%)
Figure 39 Other technologies Market Forecast by Region, 2022-2032 (US$ million)
Figure 40 Other technologies Market Share Forecast by Region, 2022 & 2032 (%)
Figure 41 Infectious Disease Diagnostics Market Forecast by Application 2022, 2027, 2032 (Revenue, CAGR%)
Figure 42 Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 43 Infectious Disease Diagnostics Market Share Forecast by Application, 2022, 2027, 2032 (%)
Figure 44 COVID-19 Market Forecast by Region, 2022-2032 (US$ million)
Figure 45 COVID-19 Market Share Forecast by Region, 2022 & 2032 (%)
Figure 46 Human Immunodeficiency Virus (HIV) Market Forecast by Region, 2022-2032 (US$ million)
Figure 47 Human Immunodeficiency Virus (HIV) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 48 Healthcare-Associated Infections (HAIs) Market Forecast by Region, 2022-2032 (US$ million)
Figure 49 Healthcare-Associated Infections (HAIs) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 50 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 51 Hepatitis Market Share Forecast by Region, 2022 & 2032 (%)
Figure 52 Human Papillomavirus (HPV) Market Forecast by Region, 2022-2032 (US$ million)
Figure 53 Human Papillomavirus (HPV) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 54 Tuberculosis (TB) Market Forecast by Region, 2022-2032 (US$ million)
Figure 55 Tuberculosis (TB) Market Share Forecast by Region, 2022 & 2032 (%)
Figure 56 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 57 Influenza Market Share Forecast by Region, 2022 & 2032 (%)
Figure 58 Other Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 59 Other Infectious Diseases Market Share Forecast by Region, 2022 & 2032 (%)
Figure 60 Infectious Disease Diagnostics Market Forecast by End User 2022, 2027, 2032 (Revenue, CAGR%)
Figure 61 Infectious Disease Diagnostics Market Forecast by End User, 2022-2032 (US$ million)
Figure 62 Infectious Disease Diagnostics Market Share Forecast by End User, 2022, 2027, 2032 (%)
Figure 63 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ million)
Figure 64 Diagnostic Laboratories Market Share Forecast by Region, 2022 & 2032 (%)
Figure 65 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ million)
Figure 66 Hospitals & Clinics Market Share Forecast by Region, 2022 & 2032 (%)
Figure 67 Research Institutes Market Forecast by Region, 2022-2032 (US$ million)
Figure 68 Research Institutes Market Share Forecast by Region, 2022 & 2032 (%)
Figure 69 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million)
Figure 70 Home Care Settings Market Share Forecast by Region, 2022 & 2032 (%)
Figure 71 Other End Users Market Forecast by Region, 2022-2032 (US$ million)
Figure 72 Other End Users Market Share Forecast by Region, 2022 & 2032 (%)
Figure 73 Infectious Disease Diagnostics Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 74 Infectious Disease Diagnostics Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 75 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%))
Figure 76 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 77 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 78 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 79 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 80 North America Infectious Disease Diagnostics Market Attractiveness Index
Figure 81 North America Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 82 North America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 83 North America Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 84 North America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 85 North America Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 86 North America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 87 North America Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 88 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 89 North America Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 90 North America Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 91 North America Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 92 North America Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 93 North America Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 94 U.S. Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 95 Canada Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 96 Europe Infectious Disease Diagnostics Market Attractiveness Index
Figure 97 Europe Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 98 Europe Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 99 Europe Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 100 Europe Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 101 Europe Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 102 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 103 Europe Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 104 Europe Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 105 Europe Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 106 Europe Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 107 Europe Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 108 Europe Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 109 Europe Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 110 Germany Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 111 UK Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 112 France Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 113 Italy Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 114 Spain Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 115 Russia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 116 Rest of Europe Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 117 Asia Pacific Infectious Disease Diagnostics Market Attractiveness Index
Figure 118 Asia Pacific Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 119 Asia Pacific Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 120 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 121 Asia Pacific Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 122 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 123 Asia Pacific Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 124 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 125 Asia Pacific Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 126 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 127 Asia Pacific Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 128 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 129 Asia Pacific Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 130 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 131 Japan Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 132 China Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 133 India Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 134 Australia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 135 South Korea Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 136 Rest of Asia Pacific Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 137 Latin America Infectious Disease Diagnostics Market Attractiveness Index
Figure 138 Latin America Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 139 Latin America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 140 Latin America Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 141 Latin America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 142 Latin America Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 143 Latin America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 144 Latin America Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 145 Latin America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 146 Latin America Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 147 Latin America Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 148 Latin America Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 149 Latin America Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 150 Latin America Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 151 Brazil Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 152 Mexico Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 153 Rest of Latin America Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 154 MEA Infectious Disease Diagnostics Market Attractiveness Index
Figure 155 MEA Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 156 MEA Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million)
Figure 157 MEA
Figure 158 MEA Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million)
Figure 159 MEA Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%)
Figure 160 MEA Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million)
Figure 161 MEA Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%)
Figure 162 MEA Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million)
Figure 163 MEA Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 164 MEA Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million)
Figure 165 MEA Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%)
Figure 166 MEA Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million)
Figure 167 MEA Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 168 GCC Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 169 South Africa Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 170 Rest of MEA Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 171 Infectious Disease Diagnostics Market: Company Share/Ranking, 2021
Figure 172 Danaher Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 173 Danaher Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 174 Danaher Corporation: Regional Market Shares, 2021
Figure 175 PerkinElmer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 176 PerkinElmer Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 177 PerkinElmer Inc.: Regional Market Shares, 2021
Figure 178 Abbott: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 179 Abbott: R&D, 2017-2021 (US$ million, AGR%)
Figure 180 Abbott: Regional Market Shares, 2021
Figure 181 BioMérieux SA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 182 BioMérieux SA: R&D, 2017-2021 (US$ million, AGR%)
Figure 183 BioMérieux SA: Regional Market Shares, 2021
Figure 184 F. Hoffmann-La Roche Ltd: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 185 F. Hoffmann-La Roche Ltd: R&D, 2017-2021 (US$ million, AGR%)
Figure 186 F. Hoffmann-La Roche Ltd: Regional Market Shares, 2021
Figure 187 Becton, Dickinson and Company: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 188 Becton, Dickinson and Company: R&D, 2017-2021 (US$ million, AGR%)
Figure 189 Becton, Dickinson and Company: Regional Market Shares, 2021
Figure 190 Bio-Rad Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 191 Bio-Rad Laboratories: R&D, 2017-2021 (US$ million, AGR%)
Figure 192 Bio-Rad Laboratories: Regional Market Shares, 2021
Figure 193 Siemens Healthineers: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 194 Siemens Healthineers: R&D, 2017-2021 (US$ million, AGR%)
Figure 195 Siemens Healthineers: Regional Market Shares, 2021
Figure 196 Thermo Fisher Scientific: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 197 Thermo Fisher Scientific: R&D, 2017-2021 (US$ million, AGR%)
Figure 198 Thermo Fisher Scientific: Regional Market Shares, 2021
Figure 199 Quidel Corporation: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 200 Quidel Corporation: R&D, 2017-2021 (US$ million, AGR%)
Figure 201 Quidel Corporation: Regional Market Shares, 2021

この商品のレポートナンバー

0000033802

TOP